Sequent Scientific Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹87.3
- Today's High:
- ₹92
- Open Price:
- ₹91.73
- 52W Low:
- ₹61.8
- 52W High:
- ₹124.25
- Prev. Close:
- ₹91.7
- Volume:
- 76491
Company Statistics
- Market Cap.:
- ₹22.37 billion
- Book Value:
- 28.123
- Revenue TTM:
- ₹14.13 billion
- Operating Margin TTM:
- -1.93%
- Gross Profit TTM:
- ₹5.63 billion
- Profit Margin:
- -9.98%
- Return on Assets TTM:
- -1.13%
- Return on Equity TTM:
- -16.38%
Company Profile
Sequent Scientific Limited had its IPO on under the ticker symbol SEQUENT.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Sequent Scientific Limited has a staff strength of 1,301 employees.
Stock update
Shares of Sequent Scientific Limited opened at ₹91.73 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹87.3 - ₹92, and closed at ₹87.61.
This is a -4.46% slip from the previous day's closing price.
A total volume of 76,491 shares were traded at the close of the day’s session.
In the last one week, shares of Sequent Scientific Limited have slipped by -4.47%.
Sequent Scientific Limited's Key Ratios
Sequent Scientific Limited has a market cap of ₹22.37 billion, indicating a price to book ratio of 3.108 and a price to sales ratio of 1.6276.
In the last 12-months Sequent Scientific Limited’s revenue was ₹14.13 billion with a gross profit of ₹5.63 billion and an EBITDA of ₹207.49 million. The EBITDA ratio measures Sequent Scientific Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Sequent Scientific Limited’s operating margin was -1.93% while its return on assets stood at -1.13% with a return of equity of -16.38%.
In Q2, Sequent Scientific Limited’s quarterly earnings growth was a positive 0% while revenue growth was a negative 2.4%.
Sequent Scientific Limited’s PE and PEG Ratio
- Forward PE
- 33.3333
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹-5.59 per share while it has a forward price to earnings multiple of 33.3333 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sequent Scientific Limited’s profitability.
Sequent Scientific Limited stock is trading at a EV to sales ratio of 1.8885 and a EV to EBITDA ratio of 33.2324. Its price to sales ratio in the trailing 12-months stood at 1.6276.
Sequent Scientific Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹15.29 billion
- Total Liabilities
- ₹5.26 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Sequent Scientific Limited ended 2024 with ₹15.29 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹15.29 billion while shareholder equity stood at ₹6.99 billion.
Sequent Scientific Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹5.26 billion in other current liabilities, 498860000.00 in common stock, ₹6.49 billion in retained earnings and ₹2.40 billion in goodwill. Its cash balance stood at ₹417.46 million and cash and short-term investments were ₹428.82 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹1.83 billion.
Sequent Scientific Limited’s total current assets stands at ₹7.90 billion while long-term investments were ₹0 and short-term investments were ₹11.36 million. Its net receivables were ₹3.41 billion compared to accounts payable of ₹2.44 billion and inventory worth ₹3.46 billion.
In 2024, Sequent Scientific Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Sequent Scientific Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹87.61
- 52-Week High
- ₹124.25
- 52-Week Low
- ₹61.8
- Analyst Target Price
- ₹
Sequent Scientific Limited stock is currently trading at ₹87.61 per share. It touched a 52-week high of ₹124.25 and a 52-week low of ₹124.25. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹91.07 and 200-day moving average was ₹82.13 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5480.9% of the company’s stock are held by insiders while 750.3% are held by institutions.
Frequently Asked Questions About Sequent Scientific Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Sequent Scientific Limited operates animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.